Literature DB >> 7023306

Cimetidine decreases theophylline clearance.

J E Jackson, J R Powell, M Wandell, J Bentley, R Dorr.   

Abstract

This study tested the hypothesis that cimetidine decreases theophylline clearance. Aminophylline (6 mg/kg) was administered intravenously both before and after cimetidine treatment in 5 healthy adults. Cimetidine (300 mg) was administered orally every 6 h for 2 days before and 18 h after the aminophylline dose. Plasma samples were collected before and for 24 h after each aminophylline dose, and theophylline concentrations were determined by an enzyme-mediated immunoassay technique. Cimetidine significantly decreased theophylline clearance, mean decrease, 39% (3.85 +/- 0.27 L/h control versus 2.34 +/- 0.23 L/h with cimetidine treatment, p less than 0.002). The apparent volume of distribution was unchanged (p greater than 0.5), whereas the elimination rate constant was significantly decreased by a mean of 42% (control, 0.091 +/- 0.013 h-1 versus 0.053 +/- 0.007 h-1 with cimetidine treatment, p less than 0.005). This corresponded to an average increase in elimination half-life of 73% (range, 50 to 97%). Cimetidine probably slowed theophylline elimination by relatively nonspecific inhibition of the hepatic microsomal mono-oxygenase system. This effect may produce clinically significant changes in serum theophylline concentrations.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7023306     DOI: 10.1164/arrd.1981.123.6.615

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  36 in total

Review 1.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

2.  Drug interactions through binding to cytochrome p 450: the experience with h2-receptor blocking agents.

Authors:  U Klotz; I W Reimann
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

4.  Lack of effect of repirinast on the pharmacokinetics of theophylline in asthmatic patients.

Authors:  K Takagi; T Kuzuya; T Horiuchi; M Nadai; R Apichartpichean; Y Ogura; T Hasegawa
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Effect of mequitazine on the pharmacokinetics of theophylline in asthmatic patients.

Authors:  T Hasegawa; K Takagi; T Kuzuya; M Nadai; R Apichartpichean; I Muraoka
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Effect of cimetidine premedication on morphine-induced ventilatory depression.

Authors:  A M Lam; J L Clement
Journal:  Can Anaesth Soc J       Date:  1984-01

Review 7.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

Review 8.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

9.  Amnesic syndrome after theophylline associated seizures: iatrogenic brain injury.

Authors:  J I O'Riordan; J Hutchinson; M X FitzGerald; M Hutchinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

Review 10.  Pharmacokinetic drug interactions with theophylline.

Authors:  J H Jonkman; R A Upton
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.